Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs ENALAPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs ENALAPRIL: Safety Overview

Metric EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL ENALAPRIL
Total FAERS Reports 7,225 7,730
Deaths Reported 141 711
Death Rate 2.0% 9.2%
Hospitalizations 535 3,919
Average Patient Age 46.5 yrs 63.5 yrs
% Female Patients 30.3% 49.3%
FDA Approval Date N/A Aug 10, 2021
Manufacturer N/A Bionpharma Inc.
Route N/A ORAL
Marketing Status N/A Prescription